Evidence has indicated that individuals with low IGF-1 could fail to exert neuroprotection against oxidative stress and neuroinflammation in the brain as a neurotrophic factor [25], and thus the activity of the GH-IGF-1 axis declines progressively with advancing age may be mechanistically involved in AD pathogenesis [26, 27]. This evidence concerns the gene GH1 and Alzheimer disease.